Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 359

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A

Open access
Lotti, Fiorenza, Jarrar, Awad M., Pai, Rish K., Hitomi, Masahiro, Lathia, Justin, Mace, Adam, Gantt, Gerald A., Sukhdeo, Kumar, DeVecchio, Jennifer, Vasanji, Amit, Leahy, Patrick, Hjelmeland, Anita B., Kalady, Matthew F., Rich, Jeremy N.·2013·Journal of Experimental Medicine

Abstract

Many solid cancers display cellular hierarchies with self-renewing, tumorigenic stemlike cells, or cancer-initiating cells (CICs) at the apex. Whereas CICs often exhibit relative resistance to conventional cancer therapies, they also receive critical maintenance cues from supportive stromal elements that also respond to cytotoxic therapies. To interrogate the interplay between chemotherapy and CICs, we investigated cellular heterogeneity in human colorectal cancers. Colorectal CICs were resistant to conventional chemotherapy in cell-autonomous assays, but CIC chemoresistance was also increased by cancer-associated fibroblasts (CAFs). Comparative analysis of matched colorectal cancer specimens from patients before and after cytotoxic treatment revealed a significant increase in CAFs. Chemotherapy-treated human CAFs promoted CIC self-renewal and in vivo tumor growth associated with increased secretion of specific cytokines and chemokines, including interleukin-17A (IL-17A). Exogenous IL-17A increased CIC self-renewal and invasion, and targeting IL-17A signaling impaired CIC growth. Notably, IL-17A was overexpressed by colorectal CAFs in response to chemotherapy with expression validated directly in patient-derived specimens without culture. These data suggest that chemotherapy induces remodeling of the tumor microenvironment to support the tumor cellular hierarchy through secreted factors. Incorporating simultaneous disruption of CIC mechanisms and interplay with the tumor microenvironment could optimize therapeutic targeting of cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20131195

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 86

  1. Arnold, 2010, Targeted treatments in colorectal cancer: state of the art and future perspectives, Gut., 59, 838, 10.1136/gut.2009.196006 · DOI
  2. Barcellos-Hoff, 2000, Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells, Cancer Res., 60, 1254
  3. Barker, 2009, Crypt stem cells as the cells-of-origin of intestinal cancer, Nature., 457, 608, 10.1038/nature07602 · DOI · Paper page
  4. Bissell, 2005, Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?, Cancer Cell., 7, 17
  5. Blache, 2004, SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes, J. Cell Biol., 166, 37, 10.1083/jcb.200311021 · DOI · Paper page
  6. Blanpain, 2013, Tracing the cellular origin of cancer, Nat. Cell Biol., 15, 126, 10.1038/ncb2657 · DOI · Paper page
  7. Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med., 3, 730, 10.1038/nm0797-730 · DOI · Paper page
  8. Bruchard, 2013, Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth, Nat. Med., 19, 57, 10.1038/nm.2999 · DOI · Paper page
  9. Calon, 2012, Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation, Cancer Cell., 22, 571, 10.1016/j.ccr.2012.08.013 · DOI · Paper page
  10. Crawford, 2009, PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment, Cancer Cell., 15, 21, 10.1016/j.ccr.2008.12.004 · DOI · Paper page
  11. Dalerba, 2007, Phenotypic characterization of human colorectal cancer stem cells, Proc. Natl. Acad. Sci. USA., 104, 10158, 10.1073/pnas.0703478104 · DOI · Paper page
  12. Dallas, 2009, Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition, Cancer Res., 69, 1951, 10.1158/0008-5472.CAN-08-2023 · DOI · Paper page
  13. De Wever, 2002, Role of myofibroblasts at the invasion front, Biol. Chem., 383, 55, 10.1515/BC.2002.006 · DOI
  14. Deng, 2010, Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers, PLoS ONE., 5, e10277, 10.1371/journal.pone.0010277 · DOI · Paper page
  15. Desmoulière, 2004, The stroma reaction myofibroblast: a key player in the control of tumor cell behavior, Int. J. Dev. Biol., 48, 509, 10.1387/ijdb.041802ad · DOI · Paper page
  16. Du, 2008, CD44 is of functional importance for colorectal cancer stem cells, Clin. Cancer Res., 14, 6751, 10.1158/1078-0432.CCR-08-1034 · DOI · Paper page
  17. Dylla, 2008, Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy, PLoS ONE., 3, e2428, 10.1371/journal.pone.0002428 · DOI · Paper page
  18. Elsaba, 2010, The stem cell marker CD133 associates with enhanced colony formation and cell motility in colorectal cancer, PLoS ONE., 5, e10714, 10.1371/journal.pone.0010714 · DOI
  19. Fang, 2010, Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery, Br. J. Cancer., 102, 1265, 10.1038/sj.bjc.6605610 · DOI
  20. Gemei, 2013, CD66c is a novel marker for colorectal cancer stem cell isolation, and its silencing halts tumor growth in vivo, Cancer., 119, 729, 10.1002/cncr.27794 · DOI
  21. Gilbert, 2011, Chemotherapeutic resistance: surviving stressful situations, Cancer Res., 71, 5062, 10.1158/0008-5472.CAN-11-0277 · DOI
  22. Gonda, 2010, Molecular biology of cancer-associated fibroblasts: can these cells be targeted in anti-cancer therapy?, Semin. Cell Dev. Biol., 21, 2, 10.1016/j.semcdb.2009.10.001 · DOI
  23. Grum-Schwensen, 2005, Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene, Cancer Res., 65, 3772, 10.1158/0008-5472.CAN-04-4510 · DOI · Paper page
  24. Guo, 2012, Slug and Sox9 cooperatively determine the mammary stem cell state, Cell., 148, 1015, 10.1016/j.cell.2012.02.008 · DOI · Paper page
  25. Hao, 2011, Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression, Leuk. Lymphoma., 52, 1787, 10.3109/10428194.2011.576791 · DOI
  26. Hellevik, 2013, Changes in the Secretory Profile of NSCLC-Associated Fibroblasts after Ablative Radiotherapy: Potential Impact on Angiogenesis and Tumor Growth, Transl Oncol., 6, 66, 10.1593/tlo.12349 · DOI
  27. Hölzel, 2013, Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?, Nat. Rev. Cancer., 13, 365, 10.1038/nrc3498 · DOI · Paper page
  28. Horst, 2009, Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer, Cancer Invest., 27, 844, 10.1080/07357900902744502 · DOI · Paper page
  29. Hu, 2009, ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays, J. Immunol. Methods., 347, 70, 10.1016/j.jim.2009.06.008 · DOI · Paper page
  30. Huang, 2009, Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis, Cancer Res., 69, 3382, 10.1158/0008-5472.CAN-08-4418 · DOI · Paper page
  31. Hueber, 2010, Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis, Sci. Transl. Med., 2, 52ra72, 10.1126/scitranslmed.3001107 · DOI · Paper page
  32. Hyun, 2012, Role of IL-17A in the development of colitis-associated cancer, Carcinogenesis., 33, 931, 10.1093/carcin/bgs106 · DOI · Paper page
  33. Jay, 2005, Expression of the carcinoembryonic antigen gene is inhibited by SOX9 in human colon carcinoma cells, Cancer Res., 65, 2193, 10.1158/0008-5472.CAN-04-1484 · doi:10.1158/0008-5472.can-04-1484
  34. Lakshman, 2004, CD44 promotes resistance to apoptosis in human colon cancer cells, Exp. Mol. Pathol., 77, 18, 10.1016/j.yexmp.2004.03.002 · DOI · Paper page
  35. Lakshman, 2005, CD44 promotes resistance to apoptosis in murine colonic epithelium, J. Cell. Physiol., 203, 583, 10.1002/jcp.20260 · doi:10.1002/jcp.20260
  36. Leonardi, 2012, Anti-interleukin-17 monoclonal antibody ixekizumab in chronic plaque psoriasis, N. Engl. J. Med., 366, 1190, 10.1056/NEJMoa1109997 · DOI · Paper page
  37. Li, 2012, Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling, Cancer Discov., 2, 840, 10.1158/2159-8290.CD-12-0101 · DOI · Paper page
  38. Lieubeau, 1994, The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development, Cancer Res., 54, 6526
  39. Liu, 2011, Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks, Cancer Res., 71, 614, 10.1158/0008-5472.CAN-10-0538 · DOI · Paper page
  40. Lu, 2013, Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1, Cancer Cell., 23, 171, 10.1016/j.ccr.2012.12.021 · DOI · Paper page
  41. Magee, 2012, Cancer stem cells: impact, heterogeneity, and uncertainty, Cancer Cell., 21, 283, 10.1016/j.ccr.2012.03.003 · DOI · Paper page
  42. Markowitz, 2009, Molecular origins of cancer: Molecular basis of colorectal cancer, N. Engl. J. Med., 361, 2449, 10.1056/NEJMra0804588 · DOI · Paper page
  43. Markowitz, 1995, Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability, Science., 268, 1336, 10.1126/science.7761852 · DOI · Paper page
  44. Matsunaga, 2003, Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia, Nat. Med., 9, 1158, 10.1038/nm909 · DOI · Paper page
  45. Medema, 2011, Microenvironmental regulation of stem cells in intestinal homeostasis and cancer, Nature., 474, 318, 10.1038/nature10212 · DOI · Paper page
  46. Medzhitov, 2009, Transcriptional control of the inflammatory response, Nat. Rev. Immunol., 9, 692, 10.1038/nri2634 · DOI · Paper page
  47. Micke, 2004, Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?, Lung Cancer., 45, S163, 10.1016/j.lungcan.2004.07.977 · DOI · Paper page
  48. Nakasone, 2012, Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance, Cancer Cell., 21, 488, 10.1016/j.ccr.2012.02.017 · DOI · Paper page
  49. Nakayama, 2002, Alpha smooth muscle actin positive stromal cells in gastric carcinoma, J. Clin. Pathol., 55, 741, 10.1136/jcp.55.10.741 · DOI
  50. O’Brien, 2007, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature., 445, 106, 10.1038/nature05372 · DOI · Paper page
  51. Ogino, 2012, How many molecular subtypes? Implications of the unique tumor principle in personalized medicine, Expert Rev. Mol. Diagn., 12, 621, 10.1586/erm.12.46 · DOI · Paper page
  52. Ohata, 2012, Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells, Cancer Res., 72, 5101, 10.1158/0008-5472.CAN-11-3812 · DOI
  53. Orimo, 2007, Heterogeneity of stromal fibroblasts in tumors, Cancer Biol. Ther., 6, 618, 10.4161/cbt.6.4.4255 · DOI
  54. Papp, 2012, Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis, N. Engl. J. Med., 366, 1181, 10.1056/NEJMoa1109017 · DOI · Paper page
  55. Park, 1999, Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts, J. Biol. Chem., 274, 36505, 10.1074/jbc.274.51.36505 · DOI · Paper page
  56. Park, 2012, Differential expression of CD133 based on microsatellite instability status in human colorectal cancer, Mol. Carcinog.
  57. Peñuelas, 2009, TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma, Cancer Cell., 15, 315, 10.1016/j.ccr.2009.02.011 · DOI · Paper page
  58. Porter, 2012, Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities, Proc. Natl. Acad. Sci. USA., 109, 13799, 10.1073/pnas.1206906109 · DOI · Paper page
  59. Ricci-Vitiani, 2007, Identification and expansion of human colon-cancer-initiating cells, Nature., 445, 111, 10.1038/nature05384 · DOI · Paper page
  60. Ricci-Vitiani, 2009, Colon cancer stem cells, J. Mol. Med., 87, 1097, 10.1007/s00109-009-0518-4 · DOI · Paper page
  61. Rønnov-Jessen, 1996, Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction, Physiol. Rev., 76, 69, 10.1152/physrev.1996.76.1.69 · DOI · Paper page
  62. Sadanandam, 2013, A colorectal cancer classification system that associates cellular phenotype and responses to therapy, Nat. Med., 19, 619, 10.1038/nm.3175 · DOI · Paper page
  63. Sanchez, 2009, Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer, Br. J. Surg., 96, 1196, 10.1002/bjs.6683 · DOI
  64. Sappino, 1988, Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues, Int. J. Cancer., 41, 707, 10.1002/ijc.2910410512 · DOI · Paper page
  65. Schäfer, 2008, Cancer as an overhealing wound: an old hypothesis revisited, Nat. Rev. Mol. Cell Biol., 9, 628, 10.1038/nrm2455 · DOI · Paper page
  66. Schuijers, 2012, Adult mammalian stem cells: the role of Wnt, Lgr5 and R-spondins, EMBO J., 31, 2685, 10.1038/emboj.2012.149 · DOI · Paper page
  67. Schwitalla, 2013, Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties, Cell., 152, 25, 10.1016/j.cell.2012.12.012 · DOI · Paper page
  68. Serini, 1999, Mechanisms of myofibroblast activity and phenotypic modulation, Exp. Cell Res., 250, 273, 10.1006/excr.1999.4543 · DOI · Paper page
  69. Shaked, 2006, Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors, Science., 313, 1785, 10.1126/science.1127592 · DOI · Paper page
  70. Shaked, 2008, Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents, Cancer Cell., 14, 263, 10.1016/j.ccr.2008.08.001 · DOI · Paper page
  71. Shmelkov, 2008, CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors, J. Clin. Invest., 118, 2111
  72. Sugimoto, 2006, Identification of fibroblast heterogeneity in the tumor microenvironment, Cancer Biol. Ther., 5, 1640, 10.4161/cbt.5.12.3354 · DOI · Paper page
  73. Takahashi, 2011, Significance of Lgr5(+ve) cancer stem cells in the colon and rectum, Ann. Surg. Oncol., 18, 1166, 10.1245/s10434-010-1373-9 · DOI
  74. Todaro, 2007, Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4, Cell Stem Cell., 1, 389, 10.1016/j.stem.2007.08.001 · DOI · Paper page
  75. Tuxhorn, 2002, Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model, Cancer Res., 62, 6021
  76. Vermeulen, 2008, Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity, Proc. Natl. Acad. Sci. USA., 105, 13427, 10.1073/pnas.0805706105 · DOI · Paper page
  77. Vermeulen, 2010, Wnt activity defines colon cancer stem cells and is regulated by the microenvironment, Nat. Cell Biol., 12, 468, 10.1038/ncb2048 · DOI · Paper page
  78. Wang, 2009, Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth, Stem Cells., 27, 2393, 10.1002/stem.188 · DOI · Paper page
  79. Washington, 2009, Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum, Arch. Pathol. Lab. Med., 133, 1539, 10.5858/133.10.1539 · DOI · Paper page
  80. Weaver, 2002, beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium, Cancer Cell., 2, 205, 10.1016/S1535-6108(02)00125-3 · DOI · Paper page
  81. Winder, 2010, Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer, Gastroenterology., 138, 2163, 10.1053/j.gastro.2010.02.005 · DOI
  82. Worthley, 2010, Stromal fibroblasts in digestive cancer, Cancer Microenviron., 3, 117, 10.1007/s12307-009-0033-8 · DOI
  83. Wu, 2009, A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses, Nat. Med., 15, 1016, 10.1038/nm.2015 · DOI · Paper page
  84. Xing, 2010, Cancer associated fibroblasts (CAFs) in tumor microenvironment, Front Biosci (Landmark Ed)., 15, 166, 10.2741/3613 · DOI · Paper page
  85. Yamauchi, 2008, Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy, Cancer Res., 68, 516, 10.1158/0008-5472.CAN-07-3063 · DOI
  86. Yeung, 2010, Cancer stem cells from colorectal cancer-derived cell lines, Proc. Natl. Acad. Sci. USA., 107, 3722, 10.1073/pnas.0915135107 · DOI · Paper page

Cited by

See all 359

Metadata

Authors
Lotti, F., Jarrar, A. M., Pai, R. K., Hitomi, M., Lathia, J., Mace, A., Gantt, G. A., Sukhdeo, K., DeVecchio, J., Vasanji, A., Leahy, P., Hjelmeland, A. B., Kalady, M. F., & Rich, J. N.
Venue
Journal of Experimental Medicine
Published
2013-12-09
Volume
210
Issue
13
Pages
2851-2872
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W2102944868
Cited by
359
References
14
FWCI
9.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. https://app.cochat.ai/papers/10.1084/jem.20131195
The paper
Lotti, F., Jarrar, A. M., Pai, R. K., Hitomi, M., Lathia, J., Mace, A., Gantt, G. A., Sukhdeo, K., DeVecchio, J., Vasanji, A., Leahy, P., Hjelmeland, A. B., Kalady, M. F., & Rich, J. N. (2013). Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20131195

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.